Skip to main content
. 2022 Sep 22;8(11):1624–1634. doi: 10.1001/jamaoncol.2022.4202

Figure 2. Incidence of Cardiac Adverse Events and Overall Survival According to SAN Dmax in the NSCLC Cohort.

Figure 2.

Cumulative incidence of AF (A), non-AF cardiac events (B), and overall survival (C) in patients with SAN Dmax of 20.0 Gy or greater and SAN Dmax less than 20.0 Gy. AF indicates atrial fibrillation; NSCLC, non–small cell lung cancer; SAN Dmax, maximum radiation dose exposed to sinoatrial node.